Goldman Sachs’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-40,000
| Closed | -$353K | – | 6896 |
|
|
2022
Q1 | $353K | Hold |
40,000
| – | – | ﹤0.01% | 5568 |
|
|
2021
Q4 | $277K | Buy |
+40,000
| New | +$587K | ﹤0.01% | 5711 |
|
|
2020
Q3 | – | Sell |
-90,000
| Closed | -$1.23M | – | 5614 |
|
|
2020
Q2 | $1.23M | Hold |
90,000
| – | – | ﹤0.01% | 3813 |
|
|
2020
Q1 | $1.17M | Buy |
+90,000
| New | +$1.6M | ﹤0.01% | 3645 |
|
|
2018
Q4 | – | Sell |
-300
| Closed | -$5K | – | 5821 |
|
|
2018
Q3 | $5K | Sell |
300
-48,100
| -99% | -$1.09M | ﹤0.01% | 5511 |
|
|
2018
Q2 | $1.43M | Buy |
48,400
+48,100
| +16,033% | +$1.52M | ﹤0.01% | 3842 |
|
|
2018
Q1 | $11K | Sell |
300
-54,900
| -99% | -$1.98M | ﹤0.01% | 5744 |
|
|
2017
Q4 | $1.75M | Sell |
55,200
-51,100
| -48% | -$1.6M | ﹤0.01% | 3894 |
|
|
2017
Q3 | $4.1M | Buy |
106,300
+76,000
| +251% | +$2.98M | ﹤0.01% | 3339 |
|
|
2017
Q2 | $1.37M | Sell |
30,300
-35,900
| -54% | -$1.37M | ﹤0.01% | 4168 |
|
|
2017
Q1 | $2.56M | Buy |
66,200
+35,800
| +118% | +$1.5M | ﹤0.01% | 3502 |
|
|
2016
Q4 | $1.16M | Sell |
30,400
-25,200
| -45% | -$1.2M | ﹤0.01% | 4321 |
|
|
2016
Q3 | $3.01M | Sell |
55,600
-279,900
| -83% | -$14.2M | ﹤0.01% | 3477 |
|
|
2016
Q2 | $12.3M | Sell |
335,500
-2,500
| -0.7% | -$88.3K | ﹤0.01% | 2159 |
|
|
2016
Q1 | $10.6M | Buy |
338,000
+87,800
| +35% | +$3.04M | ﹤0.01% | 2171 |
|
|
2015
Q4 | $15.4M | Buy |
250,200
+200,200
| +400% | +$12.6M | ﹤0.01% | 1947 |
|
|
2015
Q3 | $3.47M | Buy |
+50,000
| New | +$3.47M | ﹤0.01% | 3226 |
|
Other funds holding RDUS
Goldman Sachs's RDUS Position: Q3 2022 in Review
Goldman Sachs sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 501,164 shares — an estimated $5.2M sold.
Goldman Sachs first reported a position in RDUS in Q3 2014 and held it in 32 quarters. The position peaked at $26.7M in Q4 2015. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- Goldman Sachs reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- Goldman Sachs sold 501,164 Radius Health, Inc. shares in Q3 2022, an estimated $5.2M.
- Goldman Sachs first reported a position in Radius Health, Inc. in Q3 2014 and held it in 32 quarters.
- Goldman Sachs's Radius Health, Inc. position peaked at $26.7M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.